Login

Pınar Akpınar Oktar

ORCID: 0000-0003-3993-4292
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5104665047
Research Areas
  • Mesenchymal stem cell research
  • Pharmaceutical studies and practices
  • Acute Lymphoblastic Leukemia research
  • 3D Printing in Biomedical Research
  • Tissue Engineering and Regenerative Medicine
 Upstream Process Protocol for MSCs Isolated from Different Human-Based Tissue Origins
OPENALEX - Publications 
Pelin Kılıç Cansu Özdemir Begüm Coşar Büşra Nigar Savran Aysun Sarıkaya and 11 more Begüm Sargon Alım Toprakkale İrem Songür Özlem Kandemir Seçgin Pınar Akpınar Oktar Elif Nazli Cetindag Deniz Yurtsever Sarıca Serpil Taşdelen Üstün Ezer Emin Kürekçi Günhan Gürman

10.1007/7651_2024_553 article EN Methods in molecular biology 2024-01-01
 EVALUATION OF THE EFFICACY OF ASPARAGINASE ADDED TO CHEMOTHERAPEUTIC DRUG REGIMEN IN ACUTE LYMPHOBLASTIC LEUKEMIA BY MINIMAL RESIDUAL DISEASE MEASUREMENT
OPENALEX - Publications 
Pınar Akpınar Oktar Merve Yıldırım Güneş Rumeysa Kılıç G. Yildirim Deniz Yurtsever Sarıca and 4 more Serpil Taşdelen Türkan Patıroğlu Üstün Ezer Emin Kürekçi

B-ALL is the most common subtype of childhood Acute Lymphoblastic Leukemia (ALL), affecting approximately 85% children worldwide. Minimal Residual Disease (MRD) monitoring during treatment ALL important for prognosis disease. MRD monitoring, which enables early detection relapse, determination risk percentage and understanding effectiveness treatment, can be performed with multiple methods such as flow cytometry, qRT-PCR NGS. Asparaginase an enzyme that has been used in since 1960s,...

10.15671/hjbc.1375369 article EN Hacettepe Journal of Biology and Chemistry 2024-07-26
Coming Soon ...